9/8 Journal Club

Monday, September 11, 2023

Last week our researchers and physicians discussed a paper about bile acid metabolites, and their implications in MS research. Bile acid metabolites are signaling molecules that work throughout the central nervous system, and researchers identified lower levels of these metabolites in MS patients. Supplementing with a specific acid known as TUDCA was shown to reduce inflammation and disease severity in preliminary research. These results identify dysregulated bile acid metabolism as a potential therapeutic target in MS.

News Archive


Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy


Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.